BackgroundCheck.run
Search For

Vikram I Arora, 55Durham, NC

Vikram Arora Phones & Addresses

Durham, NC   

11105 Emerald Creek Dr, Raleigh, NC 27617    919-2944910   

3091 Angelica Dr, Corvallis, OR 97330    541-7522686   

101 Pember Pl, Morrisville, NC 27560    919-4672340   

Cary, NC   

7149 Sagert St, Tualatin, OR 97062    503-6911378   

7193 Sagert St, Tualatin, OR 97062    503-6911378   

Omaha, NE   

Wade, NC   

Mentions for Vikram I Arora

Career records & work history

Medicine Doctors

Vikram J. Arora

Specialties:
Cardiovascular Disease, Internal Medicine
Work:
Alabama Cardiovascular GroupAlabama Cardiovascular Group PC
3686 Grandview Pkwy STE 720, Birmingham, AL 35243
205-9717500 (phone) 205-9717572 (fax)
Site
Alabama Cardiovascular Group PC
48 Medical Park Dr E STE 453, Birmingham, AL 35235
205-8383895 (phone) 205-8383014 (fax)
Education:
Medical School
Armed Forces Med Coll, Univ of Pune, Pune, Maharashtra, India
Graduated: 1987
Procedures:
Cardioversion, Vaccine Administration, Angioplasty, Cardiac Catheterization, Cardiac Stress Test, Continuous EKG, Echocardiogram, Electrocardiogram (EKG or ECG)
Conditions:
Acute Myocardial Infarction (AMI), Acute Renal Failure, Angina Pectoris, Aortic Valvular Disease, Atrial Fibrillation and Atrial Flutter, Cardiac Arrhythmia, Cardiomyopathy, Conduction Disorders, Gastrointestinal Hemorrhage, Heart Failure, Ischemic Heart Disease, Ischemic Stroke, Metabolic Syndrome, Mitral Valvular Disease, Pulmonary Embolism, Substance Abuse and/or Dependency, Varicose Veins, Venous Embolism and Thrombosis, Abdominal Aortic Aneurysm, Acute Pancreatitis, Anemia, Anxiety Phobic Disorders, Aortic Aneurism, Atherosclerosis, Bronchial Asthma, Cholelethiasis or Cholecystitis, Chronic Renal Disease, Congenital Anomalies of the Heart, Diabetes Mellitus (DM), Disorders of Lipoid Metabolism, Endocarditis, Erectile Dysfunction (ED), Fractures, Dislocations, Derangement, and Sprains, Gastroesophageal Reflux Disease (GERD), Gout, Hypertension (HTN), Hypothyroidism, Iron Deficiency Anemia, Menopausal and Postmenopausal Disorders, Migraine Headache, Obstructive Sleep Apnea, Osteoarthritis, Overweight and Obesity, Paroxysmal Supreventricular Tachycardia (PSVT), Phlebitis and Thrombophlebitis, Pneumonia, Restless Leg Syndrome, Skin and Subcutaneous Infections, Transient Cerebral Ischemia, Valvular Heart Disease
Languages:
English, Spanish
Description:
Dr. Arora graduated from the Armed Forces Med Coll, Univ of Pune, Pune, Maharashtra, India in 1987. He works in Birmingham, AL and 1 other location and specializes in Cardiovascular Disease and Internal Medicine. Dr. Arora is affiliated with St Vincents East Hospital and St Vincents Hospital Birmingham.

Vikram Arora

Specialties:
Physical Medicine & Rehabilitation
Work:
Northeastern RehabilitationNortheastern Rehabilitation Associates
150 Mundy St Mac 4, Wilkes Barre, PA 18702
570-8240930 (phone) 570-8247755 (fax)
Site
Languages:
English
Description:
Dr. Arora works in Wilkes-Barre, PA and specializes in Physical Medicine & Rehabilitation. Dr. Arora is affiliated with Geisinger Wyoming Valley Hospital and Wilkes Barre General Hospital.

Vikram Arora resumes & CV records

Resumes

Vikram Arora Photo 29

Vikram Arora

Location:
United States
Vikram Arora Photo 30

Design Verification Engineer At Qualcomm

Location:
Raleigh-Durham, North Carolina Area
Industry:
Semiconductors
Vikram Arora Photo 31

Vikram Arora

Location:
United States
Vikram Arora Photo 32

Vikram Arora

Vikram Arora Photo 33

Vikram Arora

Vikram Arora Photo 34

Vikram Arora

Vikram Arora Photo 35

Vikram Arora

Vikram Arora Photo 36

Vikram Arora

Location:
United States

Publications & IP owners

Us Patents

Recombinantly Modified Plasmin

US Patent:
2010004, Feb 25, 2010
Filed:
Oct 18, 2006
Appl. No.:
12/090782
Inventors:
Philip Scuderi, JR. - Chapel Hill NC, US
Vikram Arora - Morrisville NC, US
Jennifer A. Hunt - Raleigh NC, US
Valery Novokhatny - Raleigh NC, US
International Classification:
A61K 38/48
US Classification:
424 9464
Abstract:
Methods of using polynucleotides and polypeptides relating to a recombinantly-modified plasmin(ogen) molecule are provided, including methods related to vitrectomy or vitreolysis. The plasmin(ogen) molecule has a single kringel domain N-terminal to the activation site present in the native human plasminogen molecule, and exhibits lysine-binding and significant enzymatic characteristics associated with the native enzyme.

Method, Composition, And Article Of Manufacture For Providing Alpha-1 Antitrypsin

US Patent:
2011000, Jan 6, 2011
Filed:
Oct 31, 2008
Appl. No.:
12/741030
Inventors:
Vikram Arora - Morrisville NC, US
Mohan Pamarthi - Cary NC, US
Philip Scuderi - Chapel Hill NC, US
International Classification:
A61K 38/47
A61K 38/16
C07K 14/745
A61P 31/18
US Classification:
424 9462, 514 41, 530380
Abstract:
The present invention provides a method for providing alpha-1 antitrypsin (α1-AT) to a subject, in particular a method for treating or preventing a disorder or disease associated with α1-AT deficiency in the subject, wherein the method comprises providing, subcutaneously, a therapeutically or prophylactically effective amount of α1-AT to the subject. Also provided is a composition and article of manufacture comprising α1-AT, in particular a formulation suitable for subcutaneous administration of α1-AT.

Method And Apparatus For Selectively Terminating Signals On A Bidirectional Bus Based On Bus Speed

US Patent:
2015019, Jul 9, 2015
Filed:
Mar 19, 2015
Appl. No.:
14/663303
Inventors:
- San Diego CA, US
Sumeet SETHI - San Diego CA, US
John EATON - San Diego CA, US
Vinodh CUPPU - Oceanside CA, US
Vikram ARORA - Raleigh NC, US
Vaishnav SRINIVAS - San Diego CA, US
Asim Muhammed MUNEER - San Diego CA, US
Isaac BERK - San Diego CA, US
International Classification:
H03K 19/0175
G06F 13/40
Abstract:
A method of controlling signal termination includes providing first logic for selectively terminating signals received at a first device on a bidirectional data bus, providing second logic for selectively terminating signals received at a second device on the bidirectional data bus, sending first signals from the first device to the second device on the bidirectional data bus at a first speed, stopping the sending of the first signals, after stopping the sending of the first signals, enabling the second logic and shifting a reference voltage of the second device from a first level to a second level, after enabling the second logic at the second device, sending second signals from the first device to the second device on the bidirectional data bus at a higher speed, and controlling the first logic based on a speed of signals received at the first device on the bidirectional data bus.

Method And Apparatus For Selectively Terminating Signals On A Bidirectional Bus Based On Bus Speed

US Patent:
2014025, Sep 11, 2014
Filed:
Mar 7, 2013
Appl. No.:
13/787926
Inventors:
- San Diego CA, US
Sumeet S. Sethi - San Diego CA, US
John D. Eaton - San Diego CA, US
Vinodh R. Cuppu - Oceanside CA, US
Vikram Arora - Raleigh NC, US
Vaishnav Srinivas - San Diego CA, US
Muhammad A. Muneer - San Diego CA, US
Isaac D. Berk - San Diego CA, US
Assignee:
QUALCOMM INCORPORATED - San Diego CA
International Classification:
H03K 19/0175
US Classification:
326 30
Abstract:
A method of controlling signal termination includes providing first logic for selectively terminating signals received at a first device on a bidirectional data bus, providing second logic for selectively terminating signals received at a second device on the bidirectional data bus, sending first signals from the first device to the second device on the bidirectional data bus at a first speed, stopping the sending of the first signals, after stopping the sending of the first signals, enabling the second logic and shifting a reference voltage of the second device from a first level to a second level, after enabling the second logic at the second device, sending second signals from the first device to the second device on the bidirectional data bus at a higher speed, and controlling the first logic based on a speed of signals received at the first device on the bidirectional data bus.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.